去熱原滅菌管瓶市場規模、佔有率和成長分析（按產品類型、最終用戶和地區）- 產業預測 2025-2032

2023 年去熱原無菌管瓶市場規模價值 39 億美元，預計將從 2024 年的 41.3 億美元成長到 2032 年的 65.3 億美元，預測期內（2025-2032 年）的複合年成長率為 5.9%。

由於製藥和生技領域對無菌包裝的需求不斷增加，全球去熱原無菌管瓶市場正在顯著成長。這些管瓶設計為不含有害熱原，隨著藥物開發和疫苗生產的增加，它們對於確保醫療產品的安全性和完整性至關重要。製造商正注重品質合規性和技術創新，以最大限度地降低污染風險。此外，醫療保健產業的擴張推動了市場的持續成長，凸顯了安全藥品儲存和運送的重要性。對永續性的日益關注也影響著市場，製造商正在尋求環保包裝解決方案和更節能的生產方法，以減少碳排放，同時保持產品完整性。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

去熱原無菌管瓶市場規模（依產品類型及複合年成長率） (2025-2032)

• 市場概況
• 少於 5 毫升
• 5mL～20ml
• 20mL

去熱原無菌管瓶市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 臨床實驗室
• 混合實驗室
• 製藥和生物技術公司

去熱原無菌管瓶市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Schott AG（Germany）
• Gerresheimer AG（Germany）
• Stevanato Group（Italy）
• SGD Pharma（France）
• Nipro Corporation（Japan）
• West Pharmaceutical Services, Inc.（USA）
• Corning Incorporated（USA）
• DWK Life Sciences GmbH（Germany）
• Thermo Fisher Scientific Inc.（USA）
• SiO2 Materials Science（USA）
• Ompi（Italy）
• Piramal Glass（India）
• Stoelzle Glass Group（Austria）
• Amcor plc（Australia）
• AptarGroup, Inc.（USA）
• Bormioli Pharma（Italy）
• Daikyo Seiko, Ltd.（Japan）
• Vetter Pharma International GmbH（Germany）
• Adelphi Healthcare Packaging（UK）
• Pacific Vial Manufacturing Inc.（USA）

結論和建議

Depyrogenated Sterile Empty Vials Market size was valued at USD 3.9 billion in 2023 and is poised to grow from USD 4.13 billion in 2024 to USD 6.53 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2025-2032).

The global market for depyrogenated sterile empty vials is experiencing significant growth, driven by the escalating demand for aseptic packaging in the pharmaceutical and biotech sectors. These vials, designed to be free of harmful pyrogens, are essential for ensuring the safety and integrity of medical products amid increasing drug development and vaccine production. Manufacturers are focusing on quality compliance and technological innovations to minimize contamination risks. Additionally, the healthcare industry's expansion is priming the market for sustained growth, underscoring the importance of secure drug storage and delivery. A rising emphasis on sustainability is also shaping the market, with manufacturers exploring eco-friendly packaging solutions and energy-efficient production practices to reduce their carbon footprint while maintaining product integrity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Depyrogenated Sterile Empty Vials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Depyrogenated Sterile Empty Vials Market Segments Analysis

Global Depyrogenated Sterile Empty Vials Market is segmented by Product Type, End User and region. Based on Product Type, the market is segmented into < 5 mL, 5 mL - 20ml and > 20 mL. Based on End User, the market is segmented into Clinical Labs, Compounding Labs and Pharma and Biotech Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Depyrogenated Sterile Empty Vials Market

The expansion of the pharmaceutical sector significantly fuels the need for depyrogenated sterile empty vials, which are essential for the packaging of injectable medications, vaccines, and other parenteral formulations. With the continuous growth and aging of the global population, there is an anticipated rise in the demand for pharmaceutical products, consequently elevating the need for corresponding packaging solutions. This trend underlines the vital role that depyrogenated sterile empty vials play in ensuring the safe and effective delivery of medical treatments, positioning them as a crucial element in the supply chain of the pharmaceutical industry.

Restraints in the Depyrogenated Sterile Empty Vials Market

The market for depyrogenated sterile empty vials faces certain challenges that could hinder its growth prospects. The intricate processes and rigorous quality control measures required for their production often lead to elevated manufacturing costs. Furthermore, the highly competitive landscape of the pharmaceutical sector can create significant pricing pressures, compelling manufacturers to lower their prices. This combination of increased production expenses and reduced profitability may pose substantial restraints on the overall growth of the depyrogenated sterile empty vials market, as manufacturers navigate the complexities of maintaining quality while remaining financially viable in a crowded marketplace.

Market Trends of the Depyrogenated Sterile Empty Vials Market

The Depyrogenated Sterile Empty Vials market is experiencing significant growth, largely fueled by the expanding pharmaceutical industry. As research and development in pharmaceuticals intensify, there is a rising demand for packaging solutions that ensure drug safety and efficacy, particularly for injectables. This trend is further propelled by the increasing production of biologics, vaccines, and specialized medications, all of which necessitate stringent sterility standards in packaging. As businesses strive to meet regulatory compliance and consumer safety expectations, the market for these vials is positioned for continued expansion, reflecting a robust alignment with industry needs for advanced sterile packaging solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Depyrogenated Sterile Empty Vials Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• < 5 mL
• 5 mL - 20ml
• 20 mL

Global Depyrogenated Sterile Empty Vials Market Size by End User & CAGR (2025-2032)

• Market Overview
• Clinical Labs
• Compounding Labs
• Pharma and Biotech Companies

Global Depyrogenated Sterile Empty Vials Market Size & CAGR (2025-2032)

• North America (Product Type, End User)
  • US
  • Canada
• Europe (Product Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Schott AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGD Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DWK Life Sciences GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SiO2 Materials Science (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ompi (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Glass (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stoelzle Glass Group (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amcor plc (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bormioli Pharma (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daikyo Seiko, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter Pharma International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adelphi Healthcare Packaging (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Vial Manufacturing Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations